Latest surveillance data shows a rise in antibiotic resistant infections and associated deaths

The latest national surveillance data, announced at the UK Health Security Agency (UKHSA) annual conference in Leeds today, shows that an estimated 58,224 people in England had an antibiotic resistant infection in 2022 – a rise of 4% since 2021 (55,792).

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna’s upsized IPO

Plus, news about Attralus, Sangamo, Mithra, NeOnc, 4D Molecular Therapeutics and Immix Biopharma: Immunome buys Ayala’s desmoid tumor asset: The biotech will pay $20 million

February 7, 2024

Liquidia sues FDA over exclusivity decision to delay Yutrepia’s full approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 23, 2024

Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses

Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19,

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.